Reduced gray matter volume and respiratory dysfunction in Parkinson’s disease: a voxel-based morphometry study

• Main Authors: Sieh-Yang Lee, Meng-Hsiang Chen, Pi-Ling Chiang, Hsiu-Ling Chen, Kun-Hsien Chou, Yueh-Cheng Chen, Chiun-Chieh Yu, Nai-Wen Tsai, Shau-Hsuan Li, Cheng-Hsien Lu, Wei-Che Lin
• Format: Article
• Language: English
• Published: BMC 2018-05-01
• Series: BMC Neurology
• Subjects: Parkinson’s disease; Magnetic resonance imaging; Gray matter; Respiratory system; Autonomic nervous system
• Online Access: http://link.springer.com/article/10.1186/s12883-018-1074-8

Abstract Background The respiratory dysfunction of patients with Parkinson’s disease (PD) has drawn increasing attention. This study evaluated the relationship between gray matter volume (GMV), as determined by voxel-based morphometry (VBM), and respiratory dysfunction in patients with PD and correlated it with systemic inflammatory markers. Methods Whole-brain VBM analysis was performed on 3-dimensional T1-weighted images in 25 PD patients with abnormal pulmonary function (13 men, 12 women; mean age: 62.9 ± 10.8 years) and, for comparison, on 25 sex- and age-matched PD patients with normal pulmonary function (14 men, 11 women; mean age: 62.3 ± 6.9 years). Inflammatory markers were determined by flow cytometry. The differences and correlations in regional GMV, clinical severity and inflammatory markers were determined after adjusting for age, gender and total intracranial volume (TIV). Results Compared with the normal pulmonary function group, the abnormal pulmonary function group had smaller GMV in several brain regions, including the left parahippocampal formation, right fusiform gyrus, right cerebellum crus, and left postcentral gyri. Forced expiratory volume in 1 s (FEV1) and maximal expiratory flow after expiration of 50% of forced vital capacity (MEF50) were positively correlated with regional GMV. There were no significant differences in the level of serum inflammatory markers between two groups. Conclusion Our findings suggested that involvement of the central autonomic network and GM loss may underlie the respiratory dysfunction in PD patients.